Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration. Aljundi W, Munteanu C, Seitz B, Abdin AD, et al. Graefes Arch Clin Exp Ophthalmol 2024 Apr 12. doi: 10.1007/s00417-024-06485.

Read + Share

Amedeo Smart

Independent Medical Education

Aljundi W, Munteanu C, Seitz B, Abdin AD, et al. Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2024 Apr 12. doi: 10.1007/s00417-024-06485.
PMID: 38607409